tapebrief
Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

XYL · Q2 2025 Earnings

Xylem Inc.

Reported July 31, 2025

30-second summary

Xylem posted $2.30B revenue (+6% YoY, +6% organic) with adjusted EBITDA margin of 21.8% and adjusted EPS of $1.26 — a quarterly record driven by 80-20 discipline and pricing more than offsetting tariff costs. Management raised FY2025 revenue guidance to $8.9–$9.0B and adjusted EPS to $4.70–$4.85, citing backlog execution and simplification wins (on-time performance up 600bps YoY in June). The story this quarter is internal execution outrunning a noisy macro: China orders down ~18% YoY, UK/Canada municipal timing soft, but Measurement & Control Solutions is back to outgrowth and tracking to positive book-to-bill by year-end.

Headline numbers

EPS

Q2 FY2025

$1.26

Revenue

Q2 FY2025

$2.30B

+6.1% YoY

Gross margin

Q2 FY2025

38.8%

Free cash flow

Q2 FY2025

$0.17B

Operating margin

Q2 FY2025

13.3%

Key financials

Q2 FY2025
MetricQ2 FY2025YoY
Revenue$2.30B+6.1%
EPS$1.26—
Gross margin38.8%—
Operating margin13.3%—
Free cash flow$0.17B—

Guidance

Prior quarter data unavailable — comparison not possible.

Segment KPIs

Q2 FY2025
SegmentQ2 FY2025YoY
Water Infrastructure$0.65B+3.0%
Applied Water$0.483B+6.0%
Measurement & Control Solutions$0.54B+12.0%
Water Solutions and Services$0.628B+5.0%

Other KPIs

Q2 FY2025
SegmentQ2 FY2025
Adjusted EBITDA Margin21.8%
Organic Revenue Growth6.0%
Adjusted EPS Growth16%
Net Income Margin9.8%

Management tone

Five distinct shifts versus the Q1 framing, all in the direction of higher confidence in internal control levers.

Tariffs reframed from headwind to managed cost. Q1 commentary leaned on contingency language; this quarter, CFO framing pivots to substantial offset: "Our pricing and supply chain actions more than offset inflation and tariff related costs." Management still concedes a "slightly dilutive impact on margin" from tariffs, but the posture has shifted from defensive to operational. The signal: pricing power and supply chain flexibility are doing the work the contingency reserves were built for.

Simplification moves from initiative to proof. A quarter ago the 80-20 program was a structural bet; this quarter it has quantified customer-facing wins: "In the month of June, we were up 600 basis points year-over-year on on-time performance." When operational metrics start showing up alongside financial metrics in prepared remarks, it usually means management is confident the gains are sticky rather than mix-driven.

Applied Water margin reframed as structural, not one-time. The risk on a +6% revenue segment posting outsized margin expansion is always that it's pull-forward or mix. Management pre-empted that read in Q&A, attributing roughly two-thirds of the expansion to 80-20 traction plus positive price/cost. The segment is being held out as the template for the rest of the portfolio.

MCS backlog normalization reframed from drag to inflection. Management told analysts MCS is working its backlog down to historical norms — close to $1.7B — and reiterated the commitment that MCS will be back to book-to-bill positive by year-end. A +12% reported / +10% organic print with backlog still unwinding implies underlying orders are accelerating — the year-end book-to-bill flip is the key watch item.

China escalated from monitor to active de-emphasis. Q1 treated China as a minor regional headwind; this quarter it is named explicitly — orders down ~18% YoY — and tied to a deliberate portfolio choice to walk away from parts of the business outside developed markets. This is not a forecast revision; it's a portfolio statement. Investors should expect China to remain a drag through the 80-20 prune.

Recurring themes management leaned on this quarter:

Simplification driving operational agility and margin expansionTariff mitigation through pricing and supply chain actions80-20 tool embedding cultural change, not just cost reductionM&A strategy focused on niche high-return acquisitions (VACOM, EnviroMix)Backlog normalization and MCS return to positive book-to-billMunicipal utility funding resilience despite federal policy uncertainty

Risks management surfaced:

Tariff uncertainty and potential additional Section 232 tariffsFX volatility impacting resultsChina economic weakness (orders down ~18% YoY)Municipal funding delays in UK (AMP cycle timing) and Canada (government transition)Potential EPA and state water fund cuts under Trump administration

What to watch into next quarter

MCS book-to-bill flips positive by year-end — management's commitment is explicit; failure to deliver would undercut the simplification-plus-backlog-normalization narrative

Applied Water margin durability — whether the +6% growth segment can sustain margin leadership into Q3 or whether mix/price benefits fade, testing the "two-thirds structural" claim

Q3 adjusted EBITDA margin range of 20.7%–22.2% — the low end implies sequential margin compression; watch which end of the range delivers and the commentary on tariff dilution

China orders trajectory — orders down ~18% YoY this quarter; track whether the deliberate walk-away stabilizes the run-rate or continues degrading regional revenue

UK AMP cycle and Canada municipal timing — management expects these to "snap back in the second half"; if they don't, FY guide top end becomes harder to hit

Tariff dilution magnitude — management called this "slightly dilutive" but did not quantify; any sharpening of the impact in Q3 prepared remarks would matter

Sources

  1. Xylem Inc. Q2 FY2025 earnings press release (Form 8-K Exhibit 99.1), filed July 31, 2025 — https://www.sec.gov/Archives/edgar/data/1524472/000152447225000035/xyl07312025ex991.htm
  2. Xylem Q2 FY2025 earnings call — prepared remarks (Pine, Grogan) and Q&A exchanges with Mike Halloran (Baird), Andy Kapowicz (Citi), Dean Dre (RBC), Jacob Levinson (Melius), Nathan Jones (Stifel), Tyler Bisseton for Brian Lee (Goldman), Mark Strauss (JPM), Andrew Buscaglia (BNP)

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.